ID: ALA5188413

Max Phase: Preclinical

Molecular Formula: C25H20N2O4

Molecular Weight: 412.45

Representations

Canonical SMILES:  C#CCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC

Standard InChI:  InChI=1S/C25H20N2O4/c1-4-11-30-24-20(28-2)12-16(13-21(24)29-3)22-18-10-9-15-7-5-6-8-17(15)23(18)31-25(27)19(22)14-26/h1,5-10,12-13,22H,11,27H2,2-3H3

Standard InChI Key:  OZIYMFFXZNGZRQ-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 412.45

Molecular Weight (Monoisotopic): 412.1423

AlogP: 4.09

#Rotatable Bonds: 5

Polar Surface Area: 86.73

Molecular Species: NEUTRAL

HBA: 6

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 1.68

CX LogP: 3.78

CX LogD: 3.78

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.64

Np Likeness Score: -0.80

References

1. Köhler LHF, Reich S, Yusenko M, Klempnauer KH, Shaikh AH, Ahmed K, Begemann G, Schobert R, Biersack B..  (2022)  A New Naphthopyran Derivative Combines c-Myb Inhibition, Microtubule-Targeting Effects, and Antiangiogenic Properties.,  13  (11.0): [PMID:36385941] [10.1021/acsmedchemlett.2c00403]

Source

Source(1):

• Scientific Literature